(CercleFinance.com) – Sensorion announced Monday the appointment of Scott Myers, a specialist in the biotechnology sector, as chair of its board of directors.
The hearing loss specialist said this morning that Myers would join his board as an independent member and succeed with immediate effect Edwin Moses, who has decided to focus on other commitments as chairman.
Sensorion emphasizes that the manager will bring him nearly 30 years of experience at a global level in the pharmacy and medical technology sectors.
Scott Myers is also Chairman of the Board of Directors of Dynavax Technologies and Harpoon Therapeutics, two biopharmaceutical companies listed on the Nasdaq.
Copyright © 2021 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
